ACCESSION: MSBNK-SMB_Measured-HSA001P0240013
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'BLK02_8537': {'bp': 298555.0, 'sum': 656192.0}, 'ProcedureBlank_8144': {'bp': 265446.0, 'sum': 588835.0}, 'ProcedureBlank_9023': {'bp': 157277.0, 'sum': 316285.0}, '1_posi_9254': {'bp': 148796.0, 'sum': 316980.0}, 'BLK02_8960': {'bp': 171610.0, 'sum': 441623.0}, 'BLK01_8834': {'bp': 226936.0, 'sum': 580702.0}, 'BLK02_8054': {'bp': 296835.0, 'sum': 621643.0}, 'BLK02_9084': {'bp': 177336.0, 'sum': 350090.0}, 'ProcedureBlank_8537': {'bp': 294366.0, 'sum': 643934.0}, '1_posi_8519': {'bp': 279888.0, 'sum': 650249.0}, 'BLK02_8599': {'bp': 277704.0, 'sum': 633150.0}}
COMMENT: RETENTION_TIME_STDEV 0.767
COMMENT: PRECURSOR_M/Z_RAW 240.217768
COMMENT: PRECURSOR_M/Z_STDEV 0.000143
COMMENT: PRECURSOR_IN_MS1 mz 240.218269; int 16.273; delta(ppm) 1.424716
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 257.244714; int 64.809; cor 1.000
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 199.191647; int 7.077; cor 0.915
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 199.191647; int 7.077; cor 0.915
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+H; mz 158.165149; int 42.587; cor 0.721
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 199.191647; int 7.077; cor 0.915
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.171; C12H25N5; [M+H]+; delta(ppm) -0.171397
COMMENT: PROPOSED_MF SevenGoldenRules 0.197; C10H22N4; [M+ACN+H]+; delta(ppm) -0.196786
COMMENT: PROPOSED_MF SevenGoldenRules 0.235; C8H19N3; [M+2ACN+H]+; delta(ppm) -0.235432
COMMENT: PROPOSED_MF MS-FINDER 3.331; C8H19N3; [M+2ACN+H]+; delta(ppm) 304341.185413
COMMENT: PROPOSED_MF MS-FINDER 3.272; C10H22N4; [M+ACN+H]+; delta(ppm) 66713.059174
COMMENT: PROPOSED_MF MS-FINDER 2.594; C12H25N5; [M+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.157; C12H25N5; [M+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.157; C10H22N4; [M+C2H3N+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.157; C8H19N3; [M+C4H6N2+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.765; C14H27N2O; [M+H]+; delta(ppm) -5.761103
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.765; C12H24NO; [M+C2H3N+H]+; delta(ppm) -5.761103
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.765; C10H21O; [M+C4H6N2+H]+; delta(ppm) -5.761103
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C12H25N5; [M+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H22N4; [M+C2H3N+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C8H19N3; [M+C4H6N2+H]+; delta(ppm) -0.171787
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C10H21O; [M+C4H6N2+H]+; delta(ppm) -5.761103
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.361; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+ACN+H]+; Guanethidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.947; SJNDFAUBUWEBDR-UHFFFAOYSA-N; [M+ACN+H]+; CNP0444498
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.947; VVZPFWHJZRAHKY-UHFFFAOYSA-N; [M+ACN+H]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.633; DZIUYPHPZLFPIH-UHFFFAOYSA-N; [M+2ACN+H]+; 4-(1,3-diazinan-1-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.633; DBUYWLRSTCZRIX-UHFFFAOYSA-N; [M+2ACN+H]+; CNP0430107
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.633; RITZWEITCIOIEB-UHFFFAOYSA-N; [M+2ACN+H]+; CNP0443423
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SJNDFAUBUWEBDR-UHFFFAOYSA-N; [M+ACN+H]+; CNP0444498
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VVZPFWHJZRAHKY-UHFFFAOYSA-N; [M+ACN+H]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DZIUYPHPZLFPIH-UHFFFAOYSA-N; [M+2ACN+H]+; 4-(1,3-diazinan-1-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.835; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+ACN+H]+; Guanethidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.825; DBUYWLRSTCZRIX-UHFFFAOYSA-N; [M+2ACN+H]+; CNP0430107
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.799; RITZWEITCIOIEB-UHFFFAOYSA-N; [M+2ACN+H]+; CNP0443423
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.621; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+ACN+H]+; 2-[2-(azocan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.466; RGUABPVONIGVAT-UHFFFAOYSA-N; [M+2ACN+H]+; 3-(4-methylpiperazin-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; RWTYCVWZPAKQAJ-UHFFFAOYSA-N; [M+H]+; 1-cyano-2-[3-(dimethylamino)propyl]-3-(2-methylbutan-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.907; LGDNSGSJKBIVFG-UHFFFAOYSA-N; [M+2ACN+H]+; N,N-dimethyl-2-piperazin-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.862; WUCCSASUKQHPAS-UHFFFAOYSA-N; [M+2ACN+H]+; 1,4-dimethyl-1,4,7-triazonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.667; IDVBKKCJFNEYBK-UHFFFAOYSA-N; [M+2ACN+H]+; N'-[2-(butan-2-ylideneamino)ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.567; OHHGZZZDNFJMPR-UHFFFAOYSA-N; [M+2ACN+H]+; N'-[3-(dimethylamino)propyl]propanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.532; MWCFQIQMAIQSCI-UHFFFAOYSA-N; [M+2ACN+H]+; 1-(4-methylpiperazin-1-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.340; HKGTYLFPPIRQMM-UHFFFAOYSA-N; [M+2ACN+H]+; N'-(2-pyrrolidin-1-ylethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.214; SHUQIGHJQMJUHB-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(4-ethylpiperazin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.174; DDYKTHJBSBIWNR-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(4-methyl-1,4-diazepan-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.146; VACJHYSOFQSYAC-UHFFFAOYSA-N; [M+ACN+H]+; 1-(4-aminobutyl)-2-(3-methylbut-2-enyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; WQFHGCFNHAPPTM-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(4-methylpiperazin-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.139; XDHVNMPVLPEHND-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-piperazin-1-ylethyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; LZELKEGDAZZHMY-UHFFFAOYSA-N; [M+ACN+H]+; N'-[8-(aminomethylideneamino)octyl]methanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; QGLNJLLUIYNAEO-DTORHVGOSA-N; [M+ACN+H]+; 2-[2-[(2R,6S)-2,6-dimethylpiperidin-1-yl]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; LLQZZBARQZBNEH-UHFFFAOYSA-N; [M+ACN+H]+; 2-[3-(3-methylpiperidin-1-yl)propyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; KDIMDNGDUIGURW-UHFFFAOYSA-N; [M+ACN+H]+; 2-[2-(4-methylazepan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; ILZNQIXWPJXOCK-UHFFFAOYSA-N; [M+ACN+H]+; 2-[2-[cyclohexyl(methyl)amino]ethyl]guanidine
COMMENT: CONFIDENCE Level 5: Exact mass of interest 240.218231; Observed in MS1; Charge state Unknown;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 17.417
MS$FOCUSED_ION: PRECURSOR_M/Z 240.218231
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-0190000000-e9c897e0c73ceaaeeee0
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  111.0917244 30.9724 ? 111.091940 2.2324 12.04 -0.2619 8
  113.1073518 38.0822 ? 113.107545 2.3164 10.27 0.5394 10
  127.0865994 44.8836 ? 127.086612 1.5816 10.84 0.6364 10
  154.1340212 38.2776 ? 154.133916 1.3235 9.23 0.8273 11
  156.1496901 33.1543 ? 156.149584 2.2414 7.06 0.6000 10
  170.1291176 27.2390 ? 170.129003 1.9985 6.19 0.7381 8
  222.1717103 64.4556 ? 222.171563 2.7141 25.08 0.3727 11
  240.1820540 709.4526 ? 240.181895 0.8244 82.40 0.8273 11
  240.2187250 999.0000 ? 240.218566 0.7618 0.00 1.0000 11
PK$NUM_PEAK: 9
PK$PEAK: m/z int. rel.int.
  111.091724 30.97 30
  113.107352 38.08 38
  127.086599 44.88 44
  154.134021 38.28 38
  156.149690 33.15 33
  170.129118 27.24 27
  222.171710 64.46 64
  240.182054 709.45 709
  240.218725 999.00 999
//
